Impact of Antiretroviral Therapy Eligibility Expansion on the Epidemiology of HIV-Associated Kaposi Sarcoma in Nigeria

Text Registration

Impact of Antiretroviral Therapy Eligibility Expansion on the Epidemiology of HIV-Associated Kaposi Sarcoma in Nigeria

Status

Published

on 21 Jul 2020

Year of Creation

2020

Maxwell Oluwole Akanbi

Registration Number

TX0008893634

on 21 Jul 2020

The U.S. Copyright record (Registration Number: TX0008893634) dated 21 Jul 2020, pertains to an electronic file (eService) titled "Impact of Antiretroviral Therapy Eligibility Expansion on the Epidemiology of HIV-Associated Kaposi Sarcoma in Nigeria" created in 2020. The copyright holder is Maxwell Oluwole Akanbi, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Maxwell Oluwole Akanbi.

Maxwell Oluwole Akanbi

Application Details

Registration Number

TX0008893634

Registration Date

7/21/2020

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Maxwell O Akanbi

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Impact of Antiretroviral Therapy Eligibility Expansion on the Epidemiology of HIV-Associated Kaposi Sarcoma in Nigeria

Author Statement: Maxwell O. Akanbi Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Impact of Antiretroviral Therapy Eligibility Expansion on the Epidemiology of HIV-Associated Kaposi Sarcoma in Nigeria

Author Statement: Maxwell O. Akanbi Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.